15 results
10-Q
2023 Q1
COYA
Coya Therapeutics Inc
10 May 23
Quarterly report
7:14am
exception as they are indexed to the Company’s own stock and would be classified in permanent equity if freestanding.
As of March 31, 2023 … and development expenses disaggregated and classified by clinical and preclinical, and external and internal expenses are summarized in the table below:
Three
10-K
6w76n xg6
29 Mar 23
Annual report
4:08pm
424B4
1wid10b7z951mtq lm7
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
y6mu nbpj8
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-2.1
psb1he23v qy0ej9y
18 Nov 22
IPO registration
5:06pm
S-1
abvnhc7l 5dhoyj
18 Nov 22
IPO registration
5:06pm
DRS/A
azhj y62u6dojb704
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
EX-2
ee70 cl3noq
7 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
0nid3t f5eql9pj
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
4m8yqxc 5x
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next